Curosurf

Curosurf (Poractant Alfa) is a natural surfactant used for respiratory support in premature infants. This product aids in lung function and is administered via endotracheal tube.

Curosurf is primarily used to treat respiratory distress syndrome (RDS) in premature infants. It works by replacing the natural surfactant in the lungs, which helps to improve breathing and lung function. This medication is administered directly into the lungs via an endotracheal tube, providing essential support for infants who are struggling with breathing difficulties.

Curosurf helps to reduce the surface tension in the lungs, allowing them to expand more easily. This can lead to improved oxygenation and reduced need for mechanical ventilation in premature infants. The effects are typically observed shortly after administration, providing immediate relief for respiratory distress.

Curosurf should be administered by healthcare professionals experienced in neonatal intensive care. It is important to follow proper handling and storage guidelines to ensure the effectiveness of the medication. Always consult with a healthcare provider before use.

Curosurf may interact with other medications administered via the endotracheal route. It is important to inform your healthcare provider about all medications your infant is currently taking to avoid potential interactions. Always follow the advice of a healthcare professional regarding the use of Curosurf.